Form 4 · Filed Jul 10, 2026, 10:54 PM UTC
TSHA/Taysha Gene Therapies, Inc.
Nagendran Sukumar — President and Head of R&D
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | S | sell | 200,000 | $6 | $1,248,000 | 936,410 |
Source: SEC EDGAR raw filing ↗ · Accession 0001665124-26-000013